Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia

NCT04177680 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Omega 3 pentaenoic acid
DRUG: icosapent ethyl

Sponsor

Matinas BioPharma Nanotechnologies, Inc.

Collaborators

[object Object]
[object Object]